Discover the signaling basis for OPC homeostasis
发现 OPC 稳态的信号传导基础
基本信息
- 批准号:10525872
- 负责人:
- 金额:$ 45.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-09 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressApoptosisBiologicalBiological AssayBiologyBrainCandidate Disease GeneCell CountCell Culture TechniquesCell CycleCell DensityCell LineageCell ProliferationCell SurvivalCell divisionCellsCoculture TechniquesDataData SetDegenerative DisorderDissociationEnsureEphrinsEquilibriumEventGliomaGliomagenesisGrowth FactorHealthHomeostasisLabelLigandsLightMalignant GliomaMalignant NeoplasmsMediatingModelingMolecularMosaicismNF1 geneNF1 mutationNatureNetwork-basedNeurogliaNoisePathway interactionsPatientsPatternPhosphopeptidesPlatelet-Derived Growth Factor alpha ReceptorProteinsProteomicsReagentReportingRoleSiblingsSideSignal TransductionStable Isotope LabelingSystemTP53 geneTestingTherapeuticWild Type MouseWorkYangYinYin-Yangbasecandidate validationcell regenerationcell typeexperimental studyinsightintravital imagingmouse geneticsmouse modelmutantmyelin degenerationnovel strategiesoligodendrocyte precursorphosphoproteomicsprecursor cellpreventstatistical learningsuccesstumorunsupervised learning
项目摘要
In this proposal, we will address a fundamentally important problem in glia biology: how do oligodendrocyte
precursor cells (OPCs) robustly maintain their numbers? Previous intravital imaging experiments demonstrated
that OPCs exert mutual inhibition when they contact each other, but promptly enter cell cycle when neighboring
OPCs either differentiate or die, and halt proliferation again when homeostasis is achieved. However, the
molecular basis behind OPC homeostasis remains largely unknown. Recently, using a mouse genetic system
called Mosaic Analysis of Double Markers (MADM) to model glioma, our lab discovered that OPC is a cell of
origin for glioma, and revealed that, instead of passively over-expanding, mutant OPCs actually outcompete
WT OPCs and eventually take over the entire brain. Most importantly, when we genetically blocked cell
competition of mutant OPCs, glioma can be completely prevented. Putting the observations of OPC
homeostasis in health and OPC competition in gliomagenesis together, we realized that these are the two
sides of the same coin, and that there is a Yin/Yang mechanism for OPC proliferation that counterbalances
each other in health but gets deregulated in cancer. While the Yang network of RTK signaling is well studied,
the Yin network is much less understood, let alone their counter-interactions. Here, we hypothesize that
phospho-proteomic/proteomic profiling and subsequent candidate validation using highly sensitive OPC
competition platforms should enable us to provide mechanistic insights into this Yin/Yang network. To test this
hypothesis, we have assembled a team of experts on OPC purification and culture, proteomic profiling with
limited materials, and using advanced statistical and unsupervised learning approaches to predict signaling
network based on phospho-proteomic/proteomic profiles. As a team, we have successfully performed a pilot
experiment that led to a handful of candidate genes. In Aim 1 of this proposal, we will validate the role of these
candidate genes in OPC competition. In Aim 2 of this proposal, we will perform further in-depth profiling
experiments to gain a comprehensive insight into the signaling network that controls OPC homeostasis and
competition. The findings from our project should motivate further functional studies to clearly delineate the
entire pathway, deepen our understanding of OPC homeostasis, and shed light on paradigm-shifting
therapeutic strategies for glioma based on the concept of OPC competition.
在此提案中,我们将解决神经胶质生物学的根本重要问题:少突胶质细胞如何
前体细胞(OPC)可靠地保持其数量?以前的插入成像实验证明了
当他们相互接触时,OPC会施加相互抑制,但在相邻时立即进入细胞周期
OPC可以区分或死亡,并在实现稳态时再次停止增殖。但是,
OPC稳态背后的分子基础在很大程度上仍然未知。最近,使用小鼠遗传系统
我们的实验室发现了对神经胶质瘤的模型,称为双标记(MADM),发现OPC是一个细胞
神经胶质瘤的起源,并揭示了突变的OPC实际上超过了,而不是被动过度膨胀
WT OPC,最终接管了整个大脑。最重要的是,当我们遗传阻断细胞时
突变OPC的竞争可以完全预防神经胶质瘤。提出OPC的观察
神经胶质作用的健康和OPC竞争中的体内平衡,我们意识到这是两个
同一枚硬币的一面,并且有一个阳光/杨机构用于OPC增殖,以平衡
彼此在健康方面,但在癌症中受到管制。虽然对RTK信号的Yang网络进行了充分的研究,但
阴网络的理解少得多,更不用说它们的反互动了。在这里,我们假设
使用高度敏感的OPC,磷酸化 - 蛋白质组/蛋白质组学分析和随后的候选验证
竞争平台应使我们能够为这个阴/阳网络提供机械见解。测试这个
假设,我们召集了一个专家团队OPC纯化和文化,蛋白质组学分析与
材料有限,并使用先进的统计和无监督的学习方法来预测信号
基于磷酸蛋白质组/蛋白质组谱的网络。作为一个团队,我们成功地执行了飞行员
导致少数候选基因的实验。在本提案的目标1中,我们将验证这些作用
OPC竞争中的候选基因。在该提案的目标2中,我们将进行进一步的深入分析
实验以获得控制OPC稳态和的信号网络的全面见解
竞赛。我们项目的发现应激发进一步的功能研究,以清楚地描述
整个道路,加深我们对OPC稳态的理解,并在范式转移时阐明
基于OPC竞争概念的神经胶质瘤治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hui Zong其他文献
Hui Zong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hui Zong', 18)}}的其他基金
Deconstruct tumor microenvironment in medulloblastoma
解构髓母细胞瘤的肿瘤微环境
- 批准号:
9152584 - 财政年份:2016
- 资助金额:
$ 45.31万 - 项目类别:
Deconstruct tumor microenvironment in medulloblastoma
解构髓母细胞瘤的肿瘤微环境
- 批准号:
9284536 - 财政年份:2016
- 资助金额:
$ 45.31万 - 项目类别:
Deconstruct tumor microenvironment in medulloblastoma
解构髓母细胞瘤的肿瘤微环境
- 批准号:
9513640 - 财政年份:2016
- 资助金额:
$ 45.31万 - 项目类别:
Highly specific, temporally controllable mouse genetic tools for investigating in
用于研究的高度特异性、时间可控的小鼠遗传工具
- 批准号:
8700557 - 财政年份:2013
- 资助金额:
$ 45.31万 - 项目类别:
Highly specific, temporally controllable mouse genetic tools for investigating in
用于研究的高度特异性、时间可控的小鼠遗传工具
- 批准号:
8571658 - 财政年份:2013
- 资助金额:
$ 45.31万 - 项目类别:
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa
使用 MADM(一种小鼠遗传莫萨)表征体内神经胶质瘤细胞的起源
- 批准号:
8252212 - 财政年份:2010
- 资助金额:
$ 45.31万 - 项目类别:
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa
使用 MADM(一种小鼠遗传莫萨)表征体内神经胶质瘤细胞的起源
- 批准号:
8460147 - 财政年份:2010
- 资助金额:
$ 45.31万 - 项目类别:
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa
使用 MADM(一种小鼠遗传莫萨)表征体内神经胶质瘤细胞的起源
- 批准号:
8645795 - 财政年份:2010
- 资助金额:
$ 45.31万 - 项目类别:
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa
使用 MADM(一种小鼠遗传莫萨)表征体内神经胶质瘤细胞的起源
- 批准号:
8658394 - 财政年份:2010
- 资助金额:
$ 45.31万 - 项目类别:
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa
使用 MADM(一种小鼠遗传莫萨)表征体内神经胶质瘤细胞的起源
- 批准号:
8826305 - 财政年份:2010
- 资助金额:
$ 45.31万 - 项目类别:
相似国自然基金
萱草花细胞程序性凋亡生物钟调控机制研究
- 批准号:32371943
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
超微光栅极有机光电化学晶体管生物传感器构建及其在单细胞凋亡分析中的应用研究
- 批准号:22304140
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于UCMSCs的生物人工肝通过外泌体miR-139-5p/PDE4D轴抑制细胞凋亡救治ALF的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠道微生物调控颗粒细胞凋亡参与化疗损伤性卵巢早衰发病的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CCN1诱导食管癌细胞凋亡的分子生物学途径
- 批准号:81960445
- 批准年份:2019
- 资助金额:35 万元
- 项目类别:地区科学基金项目
相似海外基金
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 45.31万 - 项目类别:
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 45.31万 - 项目类别:
The transcriptional control of vascular calcification in disease
疾病中血管钙化的转录控制
- 批准号:
10647475 - 财政年份:2023
- 资助金额:
$ 45.31万 - 项目类别:
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
- 批准号:
10648346 - 财政年份:2023
- 资助金额:
$ 45.31万 - 项目类别:
Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis
特发性肺纤维化新型治疗剂的临床前开发
- 批准号:
10696538 - 财政年份:2023
- 资助金额:
$ 45.31万 - 项目类别: